• InstaBlue Protein Stain Solution: Rapid Coomassie Gel Staini

  2026-04-30

  InstaBlue Protein Stain Solution streamlines protein visualization in polyacrylamide gels by delivering fast, sensitive staining without fixation, washing, or destaining. This reagent is optimal for workflows demanding speed, reproducibility, and compatibility with downstream mass spectrometry. It should not be used in protocols requiring methanol/acetic acid fixation or for non-protein applications.

• DAPT (GSI-IX) in Hepatobiliary Organoid Engineering and Notc

  2026-04-30

  Explore the advanced use of DAPT (GSI-IX) in hepatobiliary organoid research and Notch pathway modulation. This article uniquely highlights protocol decisions and cross-disciplinary insights for Alzheimer's disease, cancer, and stem cell applications.

• Chloroquine’s Autophagy-Dependent and Independent Roles in C

  2026-04-29

  The reviewed study systematically delineates both autophagy-dependent and autophagy-independent mechanisms of Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) in cancer therapy. By clarifying these diverse pathways and highlighting its combined pharmacotherapy potential, the paper provides a foundation for more targeted translational applications in oncology research.

• Deferoxamine Mesylate: Reliable Iron Chelation in Cell Assay

  2026-04-29

  This article provides biomedical researchers with scenario-driven, evidence-based guidance on using Deferoxamine mesylate (SKU B6068) for cell viability, proliferation, and oxidative stress assays. By addressing real laboratory challenges and integrating recent literature, it demonstrates how this iron-chelating agent from APExBIO delivers reproducible, high-quality results across cancer biology, hypoxia modeling, and wound healing workflows.

• Diclofenac in Human Intestinal Organoid Assays: A Precision

  2026-04-28

  Explore how Diclofenac, a non-selective COX inhibitor, enables advanced inflammation and pain signaling research using human intestinal organoid models. Discover protocol parameters, technical insights, and unique assay guidance not found in conventional overviews.

• Cyclosporin A: Systems Biology Insights Beyond Immunosuppres

  2026-04-28

  Explore the multifaceted role of Cyclosporin A in cellular systems biology, extending far beyond immunosuppression. This article reveals new perspectives on apoptosis modulation, mitochondrial dynamics, and translational assay design for autoimmune disorder research.

• LG 101506: Advanced RXR Modulator for Immune Checkpoint Rese

  2026-04-27

  LG 101506 stands out as a high-purity RXR modulator, uniquely enabling precise dissection of nuclear receptor signaling and immune checkpoint regulation in difficult cancer models. Its optimized performance and robust data reproducibility streamline advanced workflows in RXR signaling and immuno-oncology.

• Axitinib (AG 013736): Deep Mechanistic Insights for Angiogen

  2026-04-27

  Explore Axitinib (AG 013736) as a potent VEGFR inhibitor in cancer biology research. This article provides a granular, mechanism-centered analysis of Axitinib’s impact on angiogenesis and tumor growth, bridging advanced assay design with cutting-edge experimental insight.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-04-26

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses the need for accurate molecular weight calibration and protein transfer verification in SDS-PAGE and Western blot workflows, especially when compatibility with phosphoprotein analysis and fluorescent imaging is critical. This marker is not suitable for applications requiring non-stained, high-sensitivity detection of low-abundance proteins or workflows incompatible with pre-labeled standards.

• Axitinib (AG 013736): Precision Tools for Quantitative Angio

  2026-04-25

  Explore how Axitinib (AG 013736) empowers advanced angiogenesis inhibition assays and tumor growth studies by enabling precise dissection of VEGF signaling. This article offers a unique, quantitative perspective anchored in cutting-edge in vitro methodology.

• Indomethacin: Mechanistic Benchmarks for Inflammation Resear

  2026-04-24

  Indomethacin is a well-characterized nonsteroidal anti-inflammatory drug (NSAID) with high Cox-1 selectivity. It also acts as a PPARγ agonist and modulates membrane lipid domains, supporting advanced inflammation and lipid metabolism research. APExBIO's Indomethacin (A8449) is widely adopted for reproducibility and mechanistic clarity.

• Improving In Vitro Drug Response Evaluation in Cancer Resear

  2026-04-24

  Schwartz's dissertation rigorously distinguishes between relative and fractional viability metrics in in vitro drug response assays, revealing their differential capacity to capture proliferation arrest versus cell death. By clarifying methodological nuances, the work advances the precision of preclinical anti-cancer drug evaluation and highlights the need for careful metric selection in experimental design.

• TMEM16F Lipid Scrambling Regulates Ferroptosis and Tumor Imm

  2026-04-23

  This study identifies TMEM16F-mediated lipid scrambling as a critical suppressor of ferroptosis and demonstrates that its inhibition heightens tumor cell vulnerability and enhances immune rejection. The findings reveal new mechanistic insights and therapeutic avenues for cancer research, particularly by targeting late-stage ferroptotic events on the plasma membrane.

• SP600125: Advanced JNK Inhibitor Strategies in Inflammation

  2026-04-23

  SP600125 empowers researchers to unravel the complexities of JNK signaling in apoptosis and inflammation with unmatched selectivity and reproducibility. Explore optimized experimental designs, troubleshooting guidance, and translational insights drawn from pioneering neural differentiation studies.

• GSK2606414: PERK Inhibition, ER Stress, and the JAK1–STAT3 A

  2026-04-22

  Explore how GSK2606414, a selective PERK inhibitor, enables advanced ER stress research by dissecting the PERK/JAK1–STAT3 signaling axis. Gain practical insights, assay parameters, and translational implications for disease modeling.

16225 records 1/1082 page Next 12345 下5页 Last page